Dexmethylphenidate for attention deficit hyperactivity disorder.

Abstract

BACKGROUND:

Dexmethylphenidate is a single-isomer stimulant medication approved for the treatment of attention deficit hyperactivity disorder (ADHD). Single-isomer drugs have the potential for decreased undesired effects and improved therapeutic efficacy. Stimulant medications have been the mainstay treatments for ADHD for fifty years, and ability to reduce their adverse effects would be useful in promoting patient compliance with treatment.

OBJECTIVE:

To review the literature on the safety and efficacy of dexmethylphenidate.

METHODS:

MedLine, PubMed search of dexmethylphenidate research.

RESULTS/CONCLUSIONS:

Dexmethylphenidate is a safe and effective treatment for ADHD. Its overall safety and tolerability profile is similar to other members of the psychostimulant class.

• Authors: Daniel Coury
• Journal: Expert opinion on pharmacotherapy (Expert Opin Pharmacother) Vol. 10 Issue 16 Pg. 2679-85 (Nov 2009) ISSN: 1744-7666 [Electronic] England
• PMID: 19874250 (Publication Type: Journal Article)

Chemical References

• Central Nervous System Stimulants
• Dexmethylphenidate Hydrochloride
• Methylphenidate

Topics

• Attention Deficit Disorder with Hyperactivity (drug therapy)
• Central Nervous System Stimulants (adverse effects, pharmacokinetics, therapeutic use)
• Dexmethylphenidate Hydrochloride
• Humans
• Methylphenidate (therapeutic use)